Page 97 - Revista 2019

Cáncer colorrectal, tamizaje molecular para agregación familiar. Bohórquez et al.

al. (2016) Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II
Colorectal Cancer Patients. J Oncol. 2016:2196703.
41. Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, et al. (2009) Pathologic predic-
tors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 33(1):126-33.
42. Ashktorab H, Ahuja S, Kannan L, Llor X, Ellis NA, Xicola RM, et al. (2016) A meta-analysis of MSI
frequency and race in colorectal cancer. Oncotarget. 7(23):34546-34557.
43. Gupta S, Ashfaq R, Kapur P, Afonso BB, Nguyen TP, Ansari F, et al. (2010) Microsatellite instability
among individuals of Hispanic origin with colorectal cancer. Cancer. 116(21):4965-4972.
44. Batur S, Vuralli Bakkaloglu D, Kepil N, Erdamar S. (2016) Microsatellite instability and BRAF muta-
tion in colorectal cancer: clinicopathological characteristics and effects on survival. Bosn J Basic Med
Sci.16(4):254-260.
45. Kanth VV, Bhalsing S, Sasikala M, Rao GV, Pradeep R, Avanthi US, et al. (2014) Microsatellite ins-
tability and promoter hypermethylation in colorectal cancer in India. Tumour biol: 35(5):4347-4355.
46. Kamat N, Khidhir MA, Alashari MM, Rannug U. (2013) Microsatellite instability and loss of hete-
rozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. Oncol
Lett. 6(5):1413-1420.
47. Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offi t K, et al. (2003) Value of histopathology in predicting
microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
Am J Surg Pathol. 27(11):1407-1417.
48. Hall G, Clarkson A, Shi A, Langford E, Leung H, Eckstein RP, et al. (2010) Immunohistochemistry for
PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair defi ciency screening in
colorectal adenocarcinoma. Pathology. 42(5):409-13.
49. Raut CP, Pawlik TM, Rodriguez-Bigas MA. (2004) Clinicopathologic features in colorectal cancer
patients with microsatellite instability. Mutat Res. 568(2):275-82.
50. Jung SH, Kim SH, Kim JH. (2016) Prognostic impact of microsatellite instability in colorectal cancer
presenting with mucinous, signet-ring, and poorly differentiated cells. Ann Coloproctol. 32(2):58-65.
51. Kaya M, Basak F, Sisik A, Hasbahceci M, Bas G, Alimoglu O, et al. (2017) Validation of microsatellite
instability histology scores with Bethesda guidelines in hereditary nonpolyposis colorectal cancer. J
Cancer Res Ther. 13(2):356-61.
52. Vakiani E. (2017) Molecular Testing of Colorectal Cancer in the Modern Era: What Are We Doing and
Why? Surg pathol clin. 10(4):1009-20.
53. Alqahtani M, Grieu F, Carrello A, Amanuel B, Mashour M, Alattas R, et al. (2016) Screening for Lynch
Syndrome in young colorectal cancer patients from Saudi Arabia using microsatellite instability as the
initial test. Asian Pac J Cancer Prev. 17(4):1917-23.
54. Setaffy L, Langner C. (2015) Microsatellite instability in colorectal cancer: clinicopathological signi-
fi cance. Pol J Pathol. 66(3):203-18.
55. Boissiere-Michot F, Frugier H, Ho-Pun-Cheung A, Lopez-Crapez E, Duffour J, Bibeau F. (2016) Im-
munohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and
hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas. Virchows Arch.
469(2):135-44.
56. Shamekh R, Cives MM, J, Coppola D. (2016) Higher frequency of isolated PMS2 loss in colorectal
tumors in Colombian population: preliminary results. Pathol Lab Med Intern. 8:37-41
57. Ortiz C, Dongo-Pfl ucker K, Martin-Cruz L, Barletta Carrillo C, Mora-Alferez P, Arias A. (2016)
Microsatellite instability in patients with diagnostic of colorectal cancer. Rev Gastroenterol Peru.
36(1):15-22.
58. 5Gatalica Z, Vranic S, Xiu J, Swensen J, Reddy S. (2016) High microsatellite instability (MSI-H) co-
lorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Fam
Cancer. 15(3):405-12.
59. Kim IY. (2016) Impact of microsatellite instability in signet-ring cell and mucinous components in
patients with colorectal carcinoma. Ann Coloproctol. 32(2):45-6.
60. Kudryavtseva AV, Lipatova AV, Zaretsky AR, Moskalev AA, Fedorova MS, Rasskazova AS, et al.
(2016) Important molecular genetic markers of colorectal cancer. Oncotarget. 16;7(33):53959-83.

97
Rev. Asoc. Col. Cienc.(Col.), 2019; 31: 87-99